Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihood of Approval
RioDerm-001 is under clinical development by Rion and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase...